Although TGF-β1 is one of the most well-known inducers for EMT and the TGF-β/Smad-signaling pathway is well studied for a variety of solid tumors [29–33], the TGF-β1 driven EMT in RCC is still poorly understood. This evidence concerns the gene TGFB1 and renal cell carcinoma.